Hertraz 440mg injection online - Trastuzumab| Myapplepharma
Hertraz 440mg injection online - Trastuzumab|
Myapplepharma
Hertraz 440mg is a group of medicines which belongs to
anti neoplastic medication. Hertraz 440mg is a chemotherapy drug. It is recommended that Hertraz be administered under the guidance of a qualified physician experienced
in the use of cancer chemotherapeutic agents.
 |
| Hertraz 440mg injection |
USES
- The Hertraz 440mg injection is used alone or combination with other medicine
for the treatment in patients who suffering from metastatic breast cancer.
- The drug also indicated with combination of other
medicine for the treatment of certain types of stomach or esophagus cancer
in some persons.
WORK AS
- Different type of breast cancer cells has a higher than
normal level of a protein called HER2 (human epidermal growth factor
receptor 2) on their surface. These HER2 receptors get signals which
stimulate the tumor cells to develop and reproduce. But breast cancer
cells with too many HER2 receptors can Choice too many growth signals and
so start developing and proliferating too much and too fast.
- Hertraz 440mg
injection acts
by adhere itself to the HER2 receptors on the surface of breast cancer
cells and stopping them from collecting growth signals. By stopping the
signals, Hertraz can slow or inhibit the growth of the breast cancer and
the drug is an immune targeted therapy. In addition to inhibiting HER2
receptors, Trastuzumab can also help to fight against breast cancer by
attentive the immune system to damage the cancer cells onto which it is
attached.
- The Hertraz 440mg injection should not mix with other drugs and do not
administer as an intravenous push or bolus.
Trastuzumab should not be substitute for or with ado-Trastuzumab
emtansine
Adjuvant treatment, breast cancer:
Adjuvant treatment, breast cancer:
The drug given according
to one of the following doses and schedules for a 52 weeks total of trastuzumab
treatment:
During combination with paclitaxel, docetaxel, or docetaxel /Carboplatin:
Starting dose of 4 mg/kg as an IV (intravenous infusion) over 90 minutes followed at 2 mg/kg as an IV (intravenous infusion) over 30 minutes weekly during treatment of chemotherapy given with paclitaxel or docetaxel for first 12 weeks or 18 weeks (docetaxel/carboplatin) The Hertraz dose for One week following the last weekly administers Trastuzumab at 6 mg/kg as an IV (intravenous infusion) over 30 to 90 minutes every three weeks.
During combination with paclitaxel, docetaxel, or docetaxel /Carboplatin:
Starting dose of 4 mg/kg as an IV (intravenous infusion) over 90 minutes followed at 2 mg/kg as an IV (intravenous infusion) over 30 minutes weekly during treatment of chemotherapy given with paclitaxel or docetaxel for first 12 weeks or 18 weeks (docetaxel/carboplatin) The Hertraz dose for One week following the last weekly administers Trastuzumab at 6 mg/kg as an IV (intravenous infusion) over 30 to 90 minutes every three weeks.
The injection given as a single agent within three weeks following
completion of multi-modality, anthracycline-based chemotherapy regimens:
- For an intravenous infusion over 90 minutes: Initial
dose at 8 mg/kg
- Successive doses at 6 mg/kg over 30 to 90 minutes every
three weeks as an intravenous infusion.
- Adjuvant treatment stretching beyond one year is not
recommended.
Metastatic Treatment, Breast Cancer:
Hertraz 440mg administrated alone or in combination with
paclitaxel, at a starting dose of 4 mg/kg as a 90-minute intravenous infusion
continued by successive once weekly doses of 2 mg/kg as 30-minute intravenous
infusions until disease development. Metastatic Gastric Cancer:
Hertraz administrated at a starting dose of 8 mg/kg as a 90-minute IV intravenous infusion continued by successive doses of 6 mg/kg as an intravenous infusion over 30 to 90 minutes every three weeks until disease development.
Hertraz administrated at a starting dose of 8 mg/kg as a 90-minute IV intravenous infusion continued by successive doses of 6 mg/kg as an intravenous infusion over 30 to 90 minutes every three weeks until disease development.
Embryo fetal damage
Hertraz 440mg is
contraindicated to pregnancy period. Avoid becoming pregnancy during this
therapy. Use efficient contraceptives during treatment.
Cardiomyopathy
Patient getting Hertraz
440mg injection have
increased risk of exposing to cardiac disorders. Provide alternative therapy
management In serious condition, treatment should be discontinuing.
Pulmonary toxicity
Infusion reactions
During Hertraz
440mg injection treatment
some life-threatening infusion reactions are produced. In serious infusion reactions,
Stop the Hertraz
440mg treatment
permanently. Patient should be treated with premedication before starting the
infusion to overcome the such problem, During Hertraz
440mg injection treatment.
Use with Caution.
Therapy induced neutropenia
 |
| Hertraz 440mg injection |
DRUG INTERACTION
- In some phenomenal condition, patient should get
anthracycline, in that situation patient’s cardiac function should be
checked carefully with regular intervals.
- Do not take anthracycline treatment for 7 months after
stopping the Hertraz 440mg treatment.
- Hertraz 440mg interaction with anthracycline after ending of
Hertraz 440mg treatment may have a chance of getting cardiac problem. This
side effects occur because of Trastuzumab great disaster period is depends
on population PK analysis.
CONTRAINDICATION
Probably no
contraindicated occurs. The patients are contraindicated to the component
present in the Hertraz
440mg injection,
Hence Hypersensitivity reactions are occurring.
STORAGE
- Store the drug at 2℃
to 8℃ (refrigerator temperature) Protected the vial away
from heat & light Stored at 2℃
to 8℃ for 28 days after reconstitution Stored Hertraz 440mg diluted bag at 2℃
to 8℃ for 24 hours.
MISSED DOSE
The drug Missing doses
can decrease their usefulness and raises the probability of developing drug
resistance, that makes this drug lose their potency. For best results, it is
important to accept each scheduled dose of Trastuzumab medication as instructed.
If you miss a dose, leave the missed dose and continue with your regular dosing
schedule. Do not have two doses to make up for a missed one. If you are not
sure about what to do after missing a dose, the take advice with doctor or
pharmacist.
SIDE EFFECTS
Common side effects:
- Redness at injection site (IV)
- Muscle/joint/back pain
- Insomnia
- Tiredness
- Mild skin rash
- Stuffy nose
- Sinus pain
Serious side effects:
- Increased coughing
- Sudden unexplained weight gain
- Unusual tiredness
- Easy bruising or bleeding
- Fast or pounding heartbeat
- Increased coughing
CONTACT DETAILS
Phone : 9987711567Email : applepharmaceutical@gmail.com
Email : info@myapplepharma.com
Website : https://myapplepharma.com/hertraz-440mg.php
https://myapplepharma.com/trastuzumab.php
Comments
Post a Comment